Design Therapeutics, Inc. (DSGN)
NASDAQ: DSGN · Real-Time Price · USD
3.970
-0.050 (-1.24%)
At close: Jul 18, 2025, 4:00 PM
3.980
+0.010 (0.25%)
After-hours: Jul 18, 2025, 4:04 PM EDT
Design Therapeutics Market Cap
Design Therapeutics has a market cap or net worth of $225.94 million as of July 18, 2025. Its market cap has increased by 24.98% in one year.
Market Cap
225.94M
Enterprise Value
-1.59M
1-Year Change
24.98%
Ranking
Category
Stock Price
$3.97
Market Cap Chart
Since the IPO on March 26, 2021, Design Therapeutics's market cap has decreased from $2.21B to $225.94M, a decrease of -89.76%. That is a compound annual growth rate of -41.03%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 18, 2025 | 225.94M | -35.33% |
| Dec 31, 2024 | 349.35M | 135.41% |
| Dec 29, 2023 | 148.40M | -74.10% |
| Dec 30, 2022 | 572.92M | -51.55% |
| Dec 31, 2021 | 1.18B | -46.40% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 692.79B |
| Johnson & Johnson | 393.87B |
| AbbVie | 334.31B |
| Novo Nordisk | 287.38B |
| UnitedHealth Group | 256.40B |
| Novartis AG | 223.49B |
| Abbott Laboratories | 215.17B |
| AstraZeneca | 214.61B |